181 related articles for article (PubMed ID: 3072594)
1. [Myelodysplastic syndromes--diagnostic and therapeutic problems].
Skotnicki AB; Piatkowska-Jakubas B; Rucińska M; Zduńczyk A
Przegl Lek; 1988; 45(11):801-11. PubMed ID: 3072594
[No Abstract] [Full Text] [Related]
2. [Primary myelodysplastic syndromes].
Brohée D
Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
[No Abstract] [Full Text] [Related]
3. [Biology and clinical aspects of primary myelodysplastic syndromes].
Urbańska-Ryś H; Robak T; Krykowski E
Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
[No Abstract] [Full Text] [Related]
4. [Myelodysplastic syndromes].
Raza A; Vadhan-Raj S; Chávez-Sánchez G
Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
[No Abstract] [Full Text] [Related]
5. [Effects on bone marrow during stimulation of hematopoietic stem cells with recombinant human interleukin-3].
Falk S; Seipelt G; Ganser A; Hoelzer D; Stutte HJ; Hübner K
Verh Dtsch Ges Pathol; 1990; 74():111-5. PubMed ID: 1708566
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic and prognostic value of morphologic analysis in myelodysplastic syndromes].
Błoński JZ; Polkowska-Kulesza E
Patol Pol; 1987; 38(1):64-75. PubMed ID: 3658489
[No Abstract] [Full Text] [Related]
7. Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.
Greenberg PL
Semin Hematol; 1996 Apr; 33(2):163-75. PubMed ID: 8722686
[No Abstract] [Full Text] [Related]
8. A guide to risk assessment in the primary myelodysplastic syndrome.
Mufti GJ
Hematol Oncol Clin North Am; 1992 Jun; 6(3):587-606. PubMed ID: 1613008
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow changes in chronic relapsing polychondritis: potential appearance of myelodysplastic syndromes].
Diebold J; Rauh G; Löhrs U
Verh Dtsch Ges Pathol; 1996; 80():331. PubMed ID: 9065046
[No Abstract] [Full Text] [Related]
10. [Functional characteristics of hematopoietic and stromal cells in various forms of myelodysplastic syndrome].
Gerasimova LP; Manakova TE; Tsvetaeva NV; Lukina EA; Kozlovskaia AS
Biull Eksp Biol Med; 1999 Jan; 127(1):14-8. PubMed ID: 10189996
[No Abstract] [Full Text] [Related]
11. Competitive repopulation in leukemic and normal bone marrow.
Brecher G; Pallavicini MG; Cronkite EP
Blood Cells; 1993; 19(3):691-7; discussion 698-707. PubMed ID: 8018950
[TBL] [Abstract][Full Text] [Related]
12. Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow.
Steensma DP; Mesa RA; Reeder TL; Tefferi A; Kaufmann SH
Haematologica; 2003 Sep; 88(9):1072-4. PubMed ID: 12969818
[No Abstract] [Full Text] [Related]
13. Acute myeloblastic leukemia with trilineage myelodysplasia and CD34+ blast cells with abnormal chromatin clumping.
Gil S; Luño E; Rodriguez JA
Haematologica; 1998 Aug; 83(8):750-1. PubMed ID: 9793262
[TBL] [Abstract][Full Text] [Related]
14. Isochromosome 7q in childhood myelodysplastic syndrome.
Murray JC; Mahoney DH; Cooley LD
Leukemia; 1996 Apr; 10(4):746-7. PubMed ID: 8618458
[No Abstract] [Full Text] [Related]
15. [Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects].
Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Brusamolino E; Bernasconi P; Inverardi D
Haematologica; 1989 Oct; 74(5 Suppl):110-27. PubMed ID: 2512202
[No Abstract] [Full Text] [Related]
16. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies.
Reddy VV
Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998
[TBL] [Abstract][Full Text] [Related]
17. The study and treatment of the myelodysplastic patient.
Sanz MA; Bennett JM; Vallespí T; Hoelzer D
Rev Invest Clin; 1994 Apr; Suppl():61-73. PubMed ID: 7886312
[No Abstract] [Full Text] [Related]
18. [Bone marrow histology in myelodysplastic syndromes].
Frisch B; Bartl R
Harefuah; 1987 Jan; 112(1):1-3. PubMed ID: 3609917
[No Abstract] [Full Text] [Related]
19. [Secondary dysmyelopoiesis in patients with myelodysplastic syndromes].
Dvirnyk VN; Kokhno AV; Parovichnikova EN
Ter Arkh; 2014; 86(7):97-103. PubMed ID: 25314785
[TBL] [Abstract][Full Text] [Related]
20. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
